Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97B |
| 2 |
Microsoft
MSFT
|
+$1.32B |
| 3 |
Amgen
AMGN
|
+$1.09B |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$443M |
| 5 |
TSMC
TSM
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$993M |
| 2 |
CERN
Cerner Corp
CERN
|
+$863M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$586M |
| 4 |
AT&T
T
|
+$373M |
| 5 |
COHR
Coherent Inc
COHR
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Healthcare | 9.3% |
| 3 | Financials | 8.52% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Industrials | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
CALL
Wendy's
WEN
$1.46B
| $2.71M | ﹤0.01% |
+143,800
| New | +$2.72M |
|
|
PNT
3702
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $2.71M | ﹤0.01% |
398,797
+312,692
| +363% | +$2.39M |
|
|
TBRG
3703
DELISTED
TruBridge
TBRG
| $2.71M | ﹤0.01% |
84,902
-39,599
| -32% | -$1.28M |
|
3704
PUT
BioMarin Pharmaceuticals
BMRN
$12.1B
| $2.71M | ﹤0.01% |
+32,700
| New | +$2.6M |
|
3705
Invesco DB Agriculture Fund
DBA
$1.23B
| $2.71M | ﹤0.01% |
132,924
-41,564
| -24% | -$914K |
|
3706
Miller Industries
MLR
$613M
| $2.7M | ﹤0.01% |
119,133
+7,056
| +6% | +$179K |
|
3707
Global X Silver Miners ETF NEW
SIL
$4.7B
| $2.7M | ﹤0.01% |
104,243
+6,162
| +6% | +$198K |
|
3708
CALL
Bath & Body Works
BBWI
$4.11B
| $2.69M | ﹤0.01% |
100,000
+30,000
| +43% | +$1.3M |
|
|
CBL
3709
CBL Properties
CBL
$1.77B
| $2.69M | ﹤0.01% |
114,425
+61,997
| +118% | +$1.73M |
|
3710
Progress Software
PRGS
$1.76B
| $2.69M | ﹤0.01% |
59,329
-6,552
| -10% | -$312K |
|
3711
Paymentus
PAY
$4.83B
| $2.69M | ﹤0.01% |
200,788
+92,306
| +85% | +$1.46M |
|
3712
Addus HomeCare
ADUS
$2.24B
| $2.68M | ﹤0.01% |
32,205
-6,228
| -16% | -$522K |
|
3713
Golub Capital BDC
GBDC
$3.43B
| $2.68M | ﹤0.01% |
206,980
+191,948
| +1,277% | +$2.75M |
|
|
NETC
3714
DELISTED
Nabors Energy Transition Corp.
NETC
| $2.68M | ﹤0.01% |
267,893
| – | – |
|
3715
CALL
ARK Genomic Revolution ETF
ARKG
$1.7B
| $2.68M | ﹤0.01% |
85,000
-367,900
| -81% | -$12.9M |
|
|
HZON
3716
DELISTED
Horizon Acquisition Corporation II
HZON
| $2.68M | ﹤0.01% |
270,112
+80,854
| +43% | +$800K |
|
3717
Nkarta
NKTX
$168M
| $2.67M | ﹤0.01% |
217,170
+98,883
| +84% | +$1.3M |
|
|
CERE
3718
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $2.67M | ﹤0.01% |
101,104
+18,839
| +23% | +$535K |
|
3719
MultiSensor AI
MSAI
$11.1M
| $2.67M | ﹤0.01% |
6,712
| – | – |
|
3720
Nektar Therapeutics
NKTR
$2.49B
| $2.67M | ﹤0.01% |
46,792
+14,029
| +43% | +$885K |
|
|
RNAM
3721
DELISTED
Avidity Biosciences
RNAM
| $2.66M | ﹤0.01% |
183,283
+61,391
| +50% | +$913K |
|
|
TWCB
3722
DELISTED
Bilander Acquisition Corp. Class A Common Stock
TWCB
| $2.66M | ﹤0.01% |
275,129
-311,120
| -53% | -$3.01M |
|
|
SLCR
3723
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
| $2.66M | ﹤0.01% |
270,355
+609
| +0.2% | +$5.99K |
|
|
PARAA
3724
DELISTED
Paramount Global Class A
PARAA
| $2.66M | ﹤0.01% |
97,602
-69,669
| -42% | -$2.29M |
|
|
KNTE
3725
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.66M | ﹤0.01% |
210,958
+142,804
| +210% | +$1.33M |
|
Similar funds
Goldman Sachs's Q2 2022 Portfolio in Review
As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q2 2022 filing shows 409 new, 2,564 increased, 2,532 reduced and 542 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
- Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
- Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
- Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
- Goldman Sachs opened 409 new positions and closed 542 in Q2 2022.
- Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.
Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.